关注
Matteo Bassetti
Matteo Bassetti
Chair Infectious Diseases Clinic, University of Genoa and San Martino Hospital
在 unige.it 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
19482020
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients
OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ...
Clinical Microbiology and Infection 18, 19-37, 2012
13082012
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Importance of Combination …
M Tumbarello, P Viale, C Viscoli, EM Trecarichi, F Tumietto, A Marchese, ...
Clinical infectious diseases 55 (7), 943-950, 2012
11392012
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ...
Clinical infectious diseases 58 (8), 1072-1083, 2014
10672014
How to manage Pseudomonas aeruginosa infections
M Bassetti, A Vena, A Croxatto, E Righi, B Guery
Drugs in context 7, 2018
8462018
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ...
The Lancet Infectious Diseases 21 (6), e149-e162, 2021
7612021
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7392021
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual …
SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ...
The lancet Respiratory medicine 2 (5), 395-404, 2014
7352014
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
6402018
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ...
Intensive care medicine 46, 1127-1153, 2020
6092020
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
M Tumbarello, EM Trecarichi, FG De Rosa, M Giannella, DR Giacobbe, ...
Journal of Antimicrobial Chemotherapy 70 (7), 2133-2143, 2015
5772015
New antibiotics for bad bugs: where are we?
M Bassetti, M Merelli, C Temperoni, A Astilean
Annals of clinical microbiology and antimicrobials 12, 1-15, 2013
5712013
The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm
M Bassetti, A Vena, DR Giacobbe
European journal of clinical investigation 50 (3), e13209, 2020
5702020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a …
M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ...
The Lancet infectious diseases 21 (2), 226-240, 2021
5392021
Epidemiological trends in nosocomial candidemia in intensive care
M Bassetti, E Righi, A Costa, R Fasce, MP Molinari, R Rosso, ...
BMC Infectious Diseases 6, 1-6, 2006
4772006
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ...
Clinical Microbiology and Infection 18, 9-18, 2012
4702012
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ...
Nature medicine 27 (10), 1752-1760, 2021
4582021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli …
M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ...
Clinical Microbiology and Infection 28 (4), 521-547, 2022
4462022
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A …
E Durante-Mangoni, G Signoriello, R Andini, A Mattei, M De Cristoforo, ...
Clinical infectious diseases 57 (3), 349-358, 2013
4382013
Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial
RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ...
Infectious diseases and therapy 7 (4), 439-455, 2018
3882018
系统目前无法执行此操作,请稍后再试。
文章 1–20